My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Ventyx Biosciences, Inc. - Common Stock (NQ:VTYX)

8.740 +1.000 (+12.92%)

Streaming Delayed Price Updated: 4:00 PM EST, Dec 19, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Ventyx Biosciences, Inc. - Common Stock

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Analyst Boosts Protagonist Therapeutics Price Target, Says Psoriasis Data Impressive ↗

July 06, 2023

JMP Securities has increased the price target for Protagonist Therapeutics Inc (NASDAQ: PTGX) from $28 to $35,

Via Benzinga

Analyst Ratings for Ventyx Biosciences ↗

July 05, 2023

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

July 04, 2023

Via Benzinga

Why Shares of Ventyx Biosciences Rose Monday ↗

July 03, 2023

The company has several promising autoimmune therapies.

Via The Motley Fool

12 Health Care Stocks Moving In Monday's Intraday Session ↗

July 03, 2023

Via Benzinga

6 Analysts Have This to Say About Ventyx Biosciences ↗

June 14, 2023

Via Benzinga

The Latest Analyst Ratings for Ventyx Biosciences ↗

May 12, 2023

Via Benzinga

Recap: Ventyx Biosciences Q1 Earnings ↗

May 11, 2023

Via Benzinga

Preview: Ventyx Biosciences's Earnings ↗

May 10, 2023

Via Benzinga

Ventyx Biosciences's Earnings Outlook ↗

March 22, 2023

Via Benzinga

Why Li Auto Shares Are Trading Higher By Around 7%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

July 03, 2023

Gainers PolyMet Mining Corp. (NYSE: PLM) shares surged 144% to $1.92 after the company announced Glencore made a non-binding proposal to acquire the company for $2.11 per share.

Via Benzinga

US Stocks Mixed; Dow Falls Over 50 Points ↗

July 03, 2023

U.S. stocks traded mixed this morning, with the Dow Jones dropping more than 50 points on Monday. Following the market opening Monday, the Dow traded down 0.19% to 34,341.91 while the NASDAQ rose 0.28%...

Via Benzinga

Where Is The Current Bull Market? Scan Of Stocks Gaining Over 20% Over The Past Week Almost Exclusively Yields Biotech Names ↗

April 20, 2023

Where is the current bull market? All indications would be that it's in biotech! The broader market is not really moving. There have been plenty of attention-grabbing headlines, and earnings season is...

Via Benzinga

Analyst Expectations for Ventyx Biosciences's Future ↗

March 21, 2023

Via Benzinga

Expert Ratings for Ventyx Biosciences ↗

January 31, 2023

Via Benzinga

6 Analysts Have This to Say About Ventyx Biosciences ↗

November 17, 2022

Via Benzinga

Earnings Scheduled For May 11, 2023 ↗

May 11, 2023

Companies Reporting Before The Bell • Takeda Pharmaceutical (NYSE:TAK) is likely to report earnings for its fourth quarter. • Exela Technologies (NASDAQ:XELA) is expected to report earnings for its...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For March 21, 2023 ↗

March 21, 2023

Via Benzinga

Earnings Scheduled For March 23, 2023 ↗

March 23, 2023

Companies Reporting Before The Bell • Cognition Therapeutics (NASDAQ:CGTX) is likely to report earnings for its fourth quarter.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For December 19, 2022 ↗

December 19, 2022

Via Benzinga

Why OpGen Shares Are Trading Higher By 220%? Here Are 64 Stocks Moving In Tuesday's Mid-Day Session ↗

December 13, 2022

Gainers OpGen, Inc. (NASDAQ: OPGN) shares surged 220% to $0.3994 after the company announced topline data from its Unyvero urinary tract infections (UTI) clinical trial.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

December 13, 2022

Via Benzinga

Why Quotient Shares Are Trading Lower By More Than 48%; Here Are 37 Stocks Moving Premarket ↗

December 13, 2022

Gainers Netcapital Inc. (NASDAQ: NCPL) shares rose 91.3% to $2.65 in pre-market trading following Q2 results. Netcapital posted Q2 earnings of $0.04 per share on sales of $1.78 million.

Via Benzinga

Earnings Outlook For Ventyx Biosciences ↗

November 02, 2022

Ventyx Biosciences (NASDAQ:VTYX) is set to give its latest quarterly earnings report on Thursday, 2022-11-03. Here's what investors need to know before the announcement. Analysts estimate that Ventyx...

Via Benzinga

Stifel Maintains Buy Rating for Ventyx Biosciences: Here's What You Need To Know ↗

September 16, 2022

Stifel has decided to maintain its Buy rating of Ventyx Biosciences (NASDAQ:VTYX) and raise its price target from $45.00 to $53.00. Shares of Ventyx Biosciences are trading up 4.1% over the last 24...

Via Benzinga

Dow To $45? Here Are 5 Other Price Target Changes For Tuesday ↗

September 13, 2022

Jefferies cut the price target on Dow Inc. (NYSE: DOW) from $71 to $45. Jefferies analyst Laurence Alexander also downgraded the stock from Buy to Hold. Dow shares fell 0.8% to $50.55 in pre-market...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For November 17, 2022 ↗

November 17, 2022

Upgrades

Via Benzinga

Why Huadi International Group Shares Dipped Around 91%; Here Are 79 Biggest Movers From Yesterday ↗

November 08, 2022

Gainers

Via Benzinga

Earnings Scheduled For November 3, 2022 ↗

November 03, 2022

Companies Reporting Before The Bell • Hyatt Hotels (NYSE:H) is estimated to report quarterly earnings at $0.28 per share on revenue of $1.45 billion.

Via Benzinga

Why Tuesday Morning Shares Tumbled 31%; Here Are 66 Biggest Movers From Yesterday ↗

September 13, 2022

Gainers NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) jumped 101.3% to settle at $0.5558 on Monday after the company announced a 1-for-30 reverse stock split.

Via Benzinga

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.